Pharmaceutical

A new House health package & hospitals’ new site-neutra...

D.C. Diagnosis is STAT's twice-weekly newsletter about health care politics and ...

What could fix cancer clinical trials’ longstanding div...

When clinical trials lack diversity, that makes it difficult to understand how s...

NIH nominee Bertagnolli will get a confirmation hearing...

Monica Bertagnolli, Biden’s nominee to run the National Institutes of Health, wi...

STAT+: House transparency, PBM reform bill gains bipart...

A Democrat has signed on to a legislative package that would require health care...

How Seth Rogen and Lauren Miller Rogen are using comedy...

Since 2012, Lauren Miller Rogen and Seth Rogen have raised funds for at-home Alz...

STAT+: Lawsuit raises antitrust and kickback allegation...

Oncologists in Philadelphia are alleging Jefferson Health system is violating fe...

Obesity-related cardiovascular deaths tripled in the la...

Heart disease is killing fewer Americans overall, however, cardiovascular deaths...

STAT+: Pharmalittle: Novartis R&D hub’s name change ref...

Novartis is changing the name — and the guiding strategy — of its research and d...

AstraZeneca mulls risk strategy for Ultomiris following...

The US FDA has requested that AstraZeneca make modifications to the Ultomiris RE...

Idorsia reacquires aprocitentan rights from Janssen for...

Amid financial issues, Idorsia is hoping the resistant hypertension drug would b...

UK rejoins EU’s Horizon Europe science programme

The country returns to the EU’s research programme after a Brexit-related absenc...

Janssen’s patient programme becomes latest victim of da...

Patient information on the Janssen CarePath was accessed, but the true extent of...

Cidara gets a nod from Janssen to continue CD388 flu pr...

Cidara will also receive $7m in milestone payments for the drug-Fc conjugate as ...

Veracyte and Gustave Roussy announce partnership for ca...

Veracyte has announced a partnership with Gustave Roussy to support biopharmaceu...

IMIDomics to license TNAX’s drug candidate for IMIDs

IMIDomics has entered an agreement to license TNAX Biopharma’s IMB1001 to treat ...

Novo Nordisk and Broad Institute to explore drug target...

Novo Nordisk has entered a collaboration with The Broad Institute to detect drug...